
High Tide CEO Raj Grover Answered Shareholder Questions During Reddit AMA
PRNewsWire
公開日時: Jul 15, 2026, 10:00 PM
Sentiment Analysis
High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to announce that Founder & Chief Executive Officer Raj Grover answered shareholder questions during his fifth Reddit Ask Me Anything ("AMA") session today, on July 15, 2026, on the Company's official subreddit, r/HighTideInc. The AMA continues High Tide's long-standing commitment to direct, unfiltered engagement with its retail shareholder base, a community that has been central to the Company's growth story since its founding. Mr. Grover answered questions from shareholders and community members on the Company's strategy, operations, and outlook. The session follows an active period for High Tide, including the release of its second quarter fiscal 2026 financial results, the announced acquisition of Northern Helm, the approval of C$40 million in new senior credit facilities with BMO, and the continued scaling of the Company's international medical cannabis business in Germany through its majority stake in Remexian Pharma GmbH. ABOUT HIGH TIDE High Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including: Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 228 domestic and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products. In 2025, the Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany. Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company, with a 14% share of the German medical cannabis market, built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada. High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. CONTACT INFORMATION Media Inquiries Omar Khan Chief Communications and Public Affairs Officer High Tide Inc. [email protected] 403-770-3080 Investor Inquiries Vahan Ajamian Capital Markets Advisor High Tide Inc. [email protected] CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This news release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable securities laws (collectively, "forward-looking statements"). Forward-looking statements are often...
Source: PRNewsWire
個別の投資に関する推奨やアドバイスを提供することを意図しておりません。ここで述べられている意見や見解は、あくまでも各記事の個人的見解です。